Alvo | complete alvotech stock news by marketwatch Alvo plans on launching adalimumab and. Alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its commercialization partner in japan, fuji pharma co., ltd.
Alvo (2021)
Alvotech (nasdaq:alvo) is a global biopharmaceutical company specializing in the development, manufacturing and commercialization of biosimilar medicines
The company focuses on creating high‐quality, cost‐effective alternatives to established biologic therapies in areas such as immunology, oncology and other specialty care fields.
In my view, this makes it a relatively safer bet compared to other, more speculative biotechs
